You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotoxin

Showing 26 - 50 of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • New York, New York
    Columbia University Medical Center
Aug 4, 2021

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

Active, not recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
Apr 8, 2022

Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,

Completed
  • Fallopian Tube Cancer
  • +10 more
  • denileukin diftitox
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 13, 2019

Relapsed/Refractory Hairy Cell Leukemia Trial (Moxetumomab Pasudotox)

Approved for marketing
  • Relapsed/Refractory Hairy Cell Leukemia
  • Moxetumomab Pasudotox
  • (no location specified)
Jun 26, 2020

Recurrent Osteosarcoma Trial in Canada, Puerto Rico, United States (Glembatumumab Vedotin, Laboratory Biomarker Analysis,

Completed
Has Results
  • Recurrent Osteosarcoma
  • Glembatumumab Vedotin
  • +2 more
  • Birmingham, Alabama
  • +154 more
Jan 6, 2022

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)

Completed
Has Results
  • Male Breast Cancer
  • +5 more
  • ONTAK
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Leukemia, Cancer Trial in Houston (T-Cell Infusion Dose Level -1, T-Cell Infusion Dose Level 1, T-Cell Infusion Dose Level 2)

    Completed
    • Leukemia
    • Cancer
    • T-Cell Infusion Dose Level -1
    • +4 more
    • Houston, Texas
    • +1 more
    Jan 16, 2020

    Metastatic Melanoma Trial run by the (RFT5pdgA)

    Completed
    Has Results
    • Metastatic Melanoma
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Oct 23, 2019

    Brain and CNS Tumors Trial in Orange, Charleston (transferrin-CRM107)

    Unknown status
    • Brain and Central Nervous System Tumors
    • transferrin-CRM107
    • Orange, California
    • +1 more
    May 14, 2018

    Cell Selection for Bone Marrow Transplants to Prevent

    Completed
    • Graft vs Host Disease
    • Hematologic Neoplasm
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 14, 2019

      Adult T Cell Leukemia, Adult T Cell Lymphoma Trial in Bronx (IMTOX-25)

      Completed
      • Adult T Cell Leukemia
      • Adult T Cell Lymphoma
      • Bronx, New York
      • +6 more
      Sep 4, 2019

      Non-Hodgkin's B-cell Lymphoma Trial in Tucson, New York, Houston (MT-3724)

      No longer available
      • Non-Hodgkin's B-cell Lymphoma
      • Tucson, Arizona
      • +2 more
      Oct 9, 2019

      Leukemia, Lymphocytic, Chronic Trial run by the NCI (LMB-2)

      Completed
      Has Results
      • Leukemia
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 27, 2017

      Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)

      Withdrawn
      • Advanced Malignant Solid Neoplasm
      • +17 more
      • Glembatumumab Vedotin
      • +4 more
      • (no location specified)
      Jul 17, 2018

      Leukemia, Hairy Cell Trial in Worldwide (Moxetumomab pasudotox, IV Bag Protectant for Moxetumomab pasudotox)

      Completed
      Has Results
      • Leukemia, Hairy Cell
      • Moxetumomab pasudotox
      • IV Bag Protectant for Moxetumomab pasudotox
      • Duarte, California
      • +33 more
      Mar 27, 2020

      Leukemia Trial in Houston (Moxetumomab Pasudotox)

      Terminated
      • Leukemia
      • Moxetumomab Pasudotox
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Feb 10, 2020

      Colorectal Tumors Trial in Oslo (MOC31PE Immunotoxin)

      Completed
      • Colorectal Neoplasms
      • MOC31PE Immunotoxin
      • Oslo, Norway
        Oslo University Hospital- The Norwegian Radium Hospital
      May 24, 2017

      Leukemia, Lymphoma Trial in Minneapolis, Houston, Temple (DT2219ARL)

      Completed
      • Leukemia
      • Lymphoma
      • DT2219ARL
      • Minneapolis, Minnesota
      • +2 more
      Nov 29, 2017

      Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724

      Terminated
      Has Results
      • Non-Hodgkin's B-cell Lymphoma
      • +5 more
      • MT-3724 Phase 1
      • MT-3724 Phase 2
      • Tucson, Arizona
      • +40 more
      Jul 18, 2022

      Leukemia, Adult T-Cell Trial run by the NCI (Denileukin diftitox (Ontak))

      Terminated
      Has Results
      • Leukemia, Adult T-Cell
      • Denileukin diftitox (Ontak)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Nov 8, 2019

      Cervical Cancer, Pancreatic Cancer, Ovarian Cancer Trial run by the NCI (Fludarabine, Anti-mesothelin chimeric T cell receptor

      Terminated
      Has Results
      • Cervical Cancer
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 10, 2019

      Mesothelioma Trial run by the NCI (Multicycle SS1P, Pemetrexed, Cisplatin)

      Terminated
      • Mesothelioma
      • Multicycle SS1P
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 2, 2018

      Lung Tumors Trial run by the NCI (Anetumab Ravtansine, Blood test)

      Terminated
      Has Results
      • Lung Neoplasms
      • Anetumab Ravtansine
      • Blood test
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Apr 30, 2019

      Mesothelioma, Adenocarcinoma of Lung, Pancreatic Tumors Trial run by the NCI (Pentostatin, Cyclophosphamide, SS1(dsFv)PE38 - lot

      Completed
      Has Results
      • Mesothelioma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jun 5, 2019